| Stefanutti C, Vivenzio A, Di Giacomo S, et al. Immunoadsorption apheresis and immunosuppressive drug therapy in the treatment of complicated HCV-related cryoglobulinemia. [JOURNAL ARTICLE] J Clin Apher 2009 Nov 19. Abstract | Full Citation | | Maruyama T, Hashimoto T, Suzuki T, et al. [A case of primary testicular malignant lymphoma associated with contralateral testicural recurrence after a nine-year interval: a case report.] [JOURNAL ARTICLE] Hinyokika Kiyo 2009 Oct; 55(10):639-643. Abstract | Full Citation | | Ishii K, Urase F, Nagare Y, et al. VNCOP-B plus rituximab therapy in elderly patients with aggressive B-cell non-Hodgkin lymphoma: A multicenter experience. [JOURNAL ARTICLE] Arch Gerontol Geriatr 2009 Nov 17. Abstract | Full Citation | | Kasamon YL, Luznik L, Leffell MS, et al. Nonmyeloablative HLA-Haploidentical BMT with High-Dose Posttransplantation Cyclophosphamide: Effect of HLA Disparity on Outcome. [JOURNAL ARTICLE] Biol Blood Marrow Transplant 2009 Nov 16. Abstract | Full Citation | | Oshida K, Iwanaga E, Miyamoto K, et al. Comet assay in murine bone-marrow cell line (FDC-P2). [JOURNAL ARTICLE] Toxicol In Vitro 2009 Nov 16. Abstract | Full Citation | | Saha M, Powell AM, Bhogal B, et al. Pulsed Intravenous Cyclophosphamide and Methylprednisolone Therapy in Refractory Pemphigus. [JOURNAL ARTICLE] Br J Dermatol 2009 Nov 18. Abstract | Full Citation | | Mangano K, Nicoletti A, Patti F, et al. Variable effects of cyclophosphamide in rodent models of experimental allergic encephalomyelitis. [JOURNAL ARTICLE] Clin Exp Immunol 2009 Nov 18. Abstract | Full Citation | | Andersen RF, Rubak S, Jespersen B, et al. Early high-dose immunosuppression in Henoch-Schönlein nephrotic syndrome may improve outcome. [JOURNAL ARTICLE] Scand J Urol Nephrol 2009; 43(5):409-415. Abstract | Full Citation | Find Related Articles | | Bambury R, Gallagher F, Dodd JD, et al. Primary cardiac lymphoma: diagnostic tools and treatment challenges. [JOURNAL ARTICLE] Ir J Med Sci 2009 Nov 17. Abstract | Full Citation | | Kim YK, Sohn SK, Lee JH, et al. Clinical efficacy of a bortezomib, cyclophosphamide, thalidomide, and dexamethasone (Vel-CTD) regimen in patients with relapsed or refractory multiple myeloma: a phase II study. [JOURNAL ARTICLE] Ann Hematol 2009 Nov 18. Abstract | Full Citation | Find Related Articles |  |
|
| | Enter www.unboundmedicine.com/medline in your iPhone browser or View our Unbound MEDLINE iPhone demo Advertise on this site.
|